For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs ...

A wave of under-the-radar HIV policy changes is unfolding nationwide, with advocates warning of serious, far-reaching consequences.

Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...

Add Yahoo as a preferred source to see more of our stories on Google. A new single-pill HIV treatment has proved as effective as regimens of up to 11 tablets a day in suppressing the virus in ...

A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...

– Investigational Long-Acting, Twice-Yearly Treatment Regimen of Lenacapavir and Broadly Neutralizing Antibodies (bNAbs) Meets Primary Endpoint in Phase 2 Study and Gains Breakthrough Therapy ...

Scientists have found a breakthrough in the search for a cure for HIV, after research uncovered a development “previously thought impossible”. HIV can ‘hide’ itself in white blood cells, meaning the ...

Benjamin K. Chen, MD, PhD, discussed the next steps after the results of his study in genetic tagging showed promise in targeting HIV cells. How do you envision gene therapy working with other forms ...

Transmission electron micrograph showing hepatitis B virus particles (colored orange). The Johns Hopkins Medicine-led ...

UCSF researchers recently gave an overview of their latest work launching a new Institute for HIV Cure Research, funded by a $20 million grant from amfAR, the Foundation for AIDS Research. Cure ...

Harerimana Ismail of Uganda is a community health worker who checks on kids with HIV. He lost his salary after the Trump ...

What are the three types of HIV tests available to patients, how do they differ, and how can patients determine the best ...